Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 479

1.

Disclosure of Article Funding and Conflicts of Interest in High-Impact Clinical Journals.

Anderson TS, DeJong C, Good CB, Gellad WF.

J Gen Intern Med. 2020 Feb 3. doi: 10.1007/s11606-019-05378-9. [Epub ahead of print] No abstract available.

PMID:
32016701
2.

Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T cell dysfunction.

Singh N, Lee YG, Shestova O, Ravikumar P, Hayer KE, Hong SJ, Lu XM, Pajarillo R, Agarwal S, Kuramitsu S, Orlando EJ, Mueller KT, Good CR, Berger SL, Shalem O, Weitzman MD, Frey NV, Maude SL, Grupp SA, June CH, Gill S, Ruella M.

Cancer Discov. 2020 Jan 30. pii: CD-19-0813. doi: 10.1158/2159-8290.CD-19-0813. [Epub ahead of print]

PMID:
32001516
3.

Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose.

Essien UR, Sileanu FE, Zhao X, Liebschutz JM, Thorpe CT, Good CB, Mor MK, Radomski TR, Hausmann LRM, Fine MJ, Gellad WF.

J Gen Intern Med. 2020 Jan 21. doi: 10.1007/s11606-020-05645-0. [Epub ahead of print]

PMID:
31965528
4.

Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical Contracts.

Kannarkat JT, Good CB, Kelly E, Parekh N.

J Manag Care Spec Pharm. 2020 Jan;26(1):63-66. doi: 10.18553/jmcp.2020.26.1.63.

5.

Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization.

Gray MP, San-Juan-Rodriguez A, Chen N, Good CB, Hernandez I.

Res Social Adm Pharm. 2019 Dec 9. pii: S1551-7411(19)30777-6. doi: 10.1016/j.sapharm.2019.12.006. [Epub ahead of print]

PMID:
31864886
6.

Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition.

San-Juan-Rodriguez A, Gellad WF, Good CB, Hernandez I.

JAMA Netw Open. 2019 Dec 2;2(12):e1917379. doi: 10.1001/jamanetworkopen.2019.17379. No abstract available.

7.

Impact of Alcohol Use Disorder Treatment on Clinical Outcomes among Patients with Cirrhosis.

Rogal S, Youk A, Zhang H, Gellad WF, Fine MJ, Good CB, Chartier M, DiMartini A, Morgan T, Bataller R, Kraemer KL.

Hepatology. 2019 Nov 23. doi: 10.1002/hep.31042. [Epub ahead of print]

PMID:
31758811
8.

Adalimumab and the Challenges for Biosimilars.

Gellad WF, Good CB.

JAMA. 2019 Oct 23. doi: 10.1001/jama.2019.16275. [Epub ahead of print] No abstract available.

PMID:
31644784
9.

Review of purchases of unapproved medications by the Veterans Health Administration.

Carico RL, Emmendorfer TR, Aspinall SL, Mizah MT, Good CB.

Am J Health Syst Pharm. 2019 Nov 13;76(23):1934-1943. doi: 10.1093/ajhp/zxz227.

PMID:
31628792
10.

Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration.

Aspinall SL, Zhao X, Geraci MC, Good CB, Cunningham FE, Heron BB, Becker D, Lee S, Prasad V; Targeted Therapies in Veterans with RCC Study Group.

Cancer Med. 2019 Nov;8(15):6651-6661. doi: 10.1002/cam4.2531. Epub 2019 Sep 19.

11.

Complete Genome Sequence of a Parabacteroides distasonis Strain (CavFT hAR46) Isolated from a Gut Wall-Cavitating Microlesion in a Patient with Severe Crohn's Disease.

Yang F, Kumar A, Davenport KW, Kelliher JM, Ezeji JC, Good CE, Jacobs MR, Conger M, West G, Fiocchi C, Cominelli F, Dichosa AEK, Rodriguez-Palacios A.

Microbiol Resour Announc. 2019 Sep 5;8(36). pii: e00585-19. doi: 10.1128/MRA.00585-19.

12.

Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications.

Desai RJ, Good MM, San-Juan-Rodriguez A, Henriksen A, Cunningham F, Hernandez I, Good CB.

JAMA Netw Open. 2019 Sep 4;2(9):e1910626. doi: 10.1001/jamanetworkopen.2019.10626.

13.

Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D.

San-Juan-Rodriguez A, Good CB, Heyman RA, Parekh N, Shrank WH, Hernandez I.

JAMA Neurol. 2019 Aug 26. doi: 10.1001/jamaneurol.2019.2711. [Epub ahead of print]

PMID:
31449293
14.

Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?

Wehner GJ, Jing L, Haggerty CM, Suever JD, Leader JB, Hartzel DN, Kirchner HL, Manus JNA, James N, Ayar Z, Gladding P, Good CW, Cleland JGF, Fornwalt BK.

Eur Heart J. 2019 Aug 6. pii: ehz550. doi: 10.1093/eurheartj/ehz550. [Epub ahead of print]

PMID:
31386109
15.

Number of manufacturers and generic drug pricing from 2005 to 2017.

Hernandez I, Good CB, Gellad WF, Parekh N, He M, Shrank WH.

Am J Manag Care. 2019 Jul;25(7):348-352.

16.

Impact of an Opioid Safety Initiative on Patients Undergoing Total Knee Arthroplasty: A Time Series Analysis.

Chen Q, Hsia HL, Overman R, Bryan W, Pepin M, Mariano ER, Mudumbai SC, Buchheit T, Krishnamoorthy V, Good CB, Brookhart MA, Raghunathan K.

Anesthesiology. 2019 Aug;131(2):369-380. doi: 10.1097/ALN.0000000000002771.

PMID:
31314748
17.

Veteran Satisfaction with Early Experiences of Health Care Through the Veterans Choice Program: a Concurrent Mixed Methods Study.

Jones AL, Fine MJ, Stone RA, Gao S, Hausmann LRM, Burkitt KH, Taber PA, Switzer GE, Good CB, Vanneman ME, Zickmund SL.

J Gen Intern Med. 2019 Sep;34(9):1925-1933. doi: 10.1007/s11606-019-05116-1.

PMID:
31289992
18.

Statins for Primary Prevention of Cardiovascular Disease.

Good CB, Hernandez I, Parekh N.

Ann Intern Med. 2019 Jul 2;171(1):72. doi: 10.7326/L19-0257. No abstract available.

PMID:
31261394
19.

Determination of Multiple Sclerosis Indicators for Value-Based Contracting Using the Delphi Method.

Swart ECS, Neilson LM, Good CB, Shrank WH, Henderson R, Manolis C, Parekh N.

J Manag Care Spec Pharm. 2019 Jul;25(7):753-760. doi: 10.18553/jmcp.2019.25.7.753.

20.

Health and Psychosocial Needs of Older Adults Who Are Experiencing Homelessness Following Hospital Discharge.

Canham SL, Custodio K, Mauboules C, Good C, Bosma H.

Gerontologist. 2019 Jun 22. pii: gnz078. doi: 10.1093/geront/gnz078. [Epub ahead of print]

PMID:
31228238
21.

Sleep in the United States Military.

Good CH, Brager AJ, Capaldi VF, Mysliwiec V.

Neuropsychopharmacology. 2020 Jan;45(1):176-191. doi: 10.1038/s41386-019-0431-7. Epub 2019 Jun 11. Review.

22.

Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.

Barnes MD, Taracila MA, Good CE, Bajaksouzian S, Rojas LJ, van Duin D, Kreiswirth BN, Jacobs MR, Haldimann A, Papp-Wallace KM, Bonomo RA.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00432-19. doi: 10.1128/AAC.00432-19. Print 2019 Aug.

23.

Balancing immunosuppression and infection: recurrent enterovirus encephalitis in SLE.

Cheema S, Bunting E, Good C, Hajela V, Ridha BH, Saha RA.

Pract Neurol. 2019 Dec;19(6):508-510. doi: 10.1136/practneurol-2019-002229. Epub 2019 Jun 6.

PMID:
31171649
24.

Emergency Physician Opioid Prescribing and Risk of Long-term Use in the Veterans Health Administration: an Observational Analysis.

Barnett ML, Zhao X, Fine MJ, Thorpe CT, Sileanu FE, Cashy JP, Mor MK, Radomski TR, Hausmann LRM, Good CB, Gellad WF.

J Gen Intern Med. 2019 Aug;34(8):1522-1529. doi: 10.1007/s11606-019-05023-5. Epub 2019 May 29.

PMID:
31144281
25.

Use of a medication-based risk adjustment index to predict mortality among veterans dually-enrolled in VA and medicare.

Radomski TR, Zhao X, Hanlon JT, Thorpe JM, Thorpe CT, Naples JG, Sileanu FE, Cashy JP, Hale JA, Mor MK, Hausmann LRM, Donohue JM, Suda KJ, Stroupe KT, Good CB, Fine MJ, Gellad WF.

Healthc (Amst). 2019 Dec;7(4). pii: S2213-0764(18)30230-6. doi: 10.1016/j.hjdsi.2019.04.003. Epub 2019 Apr 26.

PMID:
31031120
26.

Papillary Fibroelastoma of the Ascending Aorta.

Al-Azizi KM, Hamandi M, Baxter R, Krueger A, Crawford AW, William M, Good C, Mead N.

J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619840377. doi: 10.1177/2324709619840377.

27.

World Health Organization Guidelines on Medicines for Diabetes Treatment Intensification.

Good CB, Kolb NR, Meyer M.

Ann Intern Med. 2019 Apr 16;170(8):583. doi: 10.7326/L19-0068. No abstract available.

PMID:
30986841
28.

Letter to the Editor: Pharmacogenomic testing is not ready for general use in psychiatry.

Severance AJ, Good CB, Schuster JM.

J Psychiatr Res. 2019 Jul;114:210. doi: 10.1016/j.jpsychires.2019.04.003. Epub 2019 Apr 6. No abstract available.

PMID:
30981422
29.

Comparison of genotoxic versus nongenotoxic stabilization of p53 provides insight into parallel stress-responsive transcriptional networks.

Catizone AN, Good CR, Alexander KA, Berger SL, Sammons MA.

Cell Cycle. 2019 Apr;18(8):809-823. doi: 10.1080/15384101.2019.1593643. Epub 2019 Apr 9.

30.

Correlating effluent concentrations and bench-scale experiments to assess the transformation of endocrine active compounds in wastewater by UV or chlorination disinfection.

Molé RA, Good CJ, Stebel EK, Higgins JF, Pitell SA, Welch AR, Minarik TA, Schoenfuss HL, Edmiston PL.

Chemosphere. 2019 Jul;226:565-575. doi: 10.1016/j.chemosphere.2019.03.145. Epub 2019 Mar 25.

PMID:
30953901
31.

Savings from the EpiPen Authorized Generic: a Retrospective Analysis of Medicaid Data.

Hernandez I, Shrank WH, Good CB, Gellad WF.

J Gen Intern Med. 2019 Sep;34(9):1682-1684. doi: 10.1007/s11606-019-04989-6. No abstract available.

PMID:
30945066
32.

Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018.

Hernandez I, Good CB, Shrank WH, Gellad WF.

JAMA. 2019 Apr 23;321(16):1627-1629. doi: 10.1001/jama.2019.2990. No abstract available.

33.

Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent.

Barnes MD, Kumar V, Bethel CR, Moussa SH, O'Donnell J, Rutter JD, Good CE, Hujer KM, Hujer AM, Marshall SH, Kreiswirth BN, Richter SS, Rather PN, Jacobs MR, Papp-Wallace KM, van den Akker F, Bonomo RA.

mBio. 2019 Mar 12;10(2). pii: e00159-19. doi: 10.1128/mBio.00159-19.

34.

Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control Study.

Moyo P, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Donohue JM, Hausmann LRM, Hanlon JT, Good CB, Fine MJ, Gellad WF.

Ann Intern Med. 2019 Apr 2;170(7):433-442. doi: 10.7326/M18-2574. Epub 2019 Mar 12.

35.

Type III interferon signaling restricts enterovirus 71 infection of goblet cells.

Good C, Wells AI, Coyne CB.

Sci Adv. 2019 Mar 6;5(3):eaau4255. doi: 10.1126/sciadv.aau4255. eCollection 2019 Mar.

36.

Multi-scale stochastic organization-oriented coarse-graining exemplified on the human mitotic checkpoint.

Henze R, Mu C, Puljiz M, Kamaleson N, Huwald J, Haslegrave J, di Fenizio PS, Parker D, Good C, Rowe JE, Ibrahim B, Dittrich P.

Sci Rep. 2019 Mar 7;9(1):3902. doi: 10.1038/s41598-019-40648-w.

37.

Identifying Outcome Measures for Coronary Artery Disease Value-Based Contracting Using the Delphi Method.

Neilson LM, Swart ECS, Good CB, Shrank WH, Henderson R, Manolis C, Parekh N.

Cardiol Ther. 2019 Jun;8(1):135-143. doi: 10.1007/s40119-019-0132-7. Epub 2019 Mar 1.

38.

Identifying Outcome Measures for Type 2 Diabetes Value-Based Contracting Using the Delphi Method.

Neilson LM, Swart ECS, Good CB, Shrank WH, Henderson R, Manolis C, Parekh N.

J Manag Care Spec Pharm. 2019 Mar;25(3):324-331. doi: 10.18553/jmcp.2019.25.3.324.

39.

Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors.

San-Juan-Rodriguez A, Prokopovich MV, Shrank WH, Good CB, Hernandez I.

JAMA Intern Med. 2019 May 1;179(5):713-716. doi: 10.1001/jamainternmed.2018.7656. No abstract available.

40.

Adverse drug reactions in the Veterans Affairs healthcare system: Frequency, severity, and causative medications analyzed by patient age.

Moore VR, Glassman PA, Au A, Good CB, Leadholm TC, Cunningham FE.

Am J Health Syst Pharm. 2019 Feb 9;76(5):312-319. doi: 10.1093/ajhp/zxy059.

PMID:
30753290
41.

Deprescribing in Advanced Illness: Aligning Patient, Clinician, and Health Plan Goals.

Parekh N, Schenker Y, Good CB, Neilson L, Shrank WH.

J Gen Intern Med. 2019 Apr;34(4):631-633. doi: 10.1007/s11606-019-04845-7. Epub 2019 Feb 4.

PMID:
30719644
42.

Brief Commentary: Treating Pain-The Cannabis Conundrum.

Good CB, Parekh N, Fischer K, Schuster J, Manolis C, Shrank W.

Ann Intern Med. 2019 Jan 15;170(2):123. doi: 10.7326/M18-3237. Epub 2019 Jan 8. No abstract available.

PMID:
30615783
43.

The Contribution Of New Product Entry Versus Existing Product Inflation In The Rising Costs Of Drugs.

Hernandez I, Good CB, Cutler DM, Gellad WF, Parekh N, Shrank WH.

Health Aff (Millwood). 2019 Jan;38(1):76-83. doi: 10.1377/hlthaff.2018.05147.

PMID:
30615532
44.

Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence.

Good CB, Parekh N, Hernandez I.

BMC Med. 2018 Dec 18;16(1):238. doi: 10.1186/s12916-018-1231-3.

45.

Patterns of opioid prescriptions received prior to unintentional prescription opioid overdose death among Veterans.

Moyo P, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Donohue JM, Hausmann LRM, Hanlon JT, Good CB, Fine MJ, Gellad WF.

Res Social Adm Pharm. 2019 Aug;15(8):1007-1013. doi: 10.1016/j.sapharm.2018.10.023. Epub 2018 Oct 17.

46.

Characteristics of Opioid Prescriptions to Veterans With Cirrhosis.

Rogal SS, Beste LA, Youk A, Fine MJ, Ketterer B, Zhang H, Leipertz S, Chartier M, Good CB, Kraemer KL, Chinman M, Morgan T, Gellad WF.

Clin Gastroenterol Hepatol. 2019 May;17(6):1165-1174.e3. doi: 10.1016/j.cgh.2018.10.021. Epub 2018 Oct 17.

PMID:
30342261
47.

Effect of Dual Use of Veterans Affairs and Medicare Part D Drug Benefits on Antihypertensive Medication Supply in a National Cohort of Veterans with Dementia.

Thorpe CT, Gellad WF, Mor MK, Cashy JP, Pleis JR, Van Houtven CH, Schleiden LJ, Hanlon JT, Niznik JD, Carico RL Jr, Good CB, Thorpe JM.

Health Serv Res. 2018 Dec;53 Suppl 3:5375-5401. doi: 10.1111/1475-6773.13055. Epub 2018 Oct 16.

48.

Ethical Obligations Regarding Short-Term Global Health Clinical Experiences.

Good CB, Kolb NR, Nakaishi L, Meyer M.

Ann Intern Med. 2018 Oct 16;169(8):588-589. doi: 10.7326/L18-0384. No abstract available.

PMID:
30326094
49.

ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases.

Jacobs MR, Abdelhamed AM, Good CE, Rhoads DD, Hujer KM, Hujer AM, Domitrovic TN, Rudin SD, Richter SS, van Duin D, Kreiswirth BN, Greco C, Fouts DE, Bonomo RA.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01801-18. doi: 10.1128/AAC.01801-18. Print 2019 Jan.

50.

Receipt of Overlapping Opioid and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Medicare Part D and the Department of Veterans Affairs: A Cross-sectional Study.

Carico R, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Hausmann LRM, Donohue JM, Suda KJ, Stroupe K, Hanlon JT, Good CB, Fine MJ, Gellad WF.

Ann Intern Med. 2018 Nov 6;169(9):593-601. doi: 10.7326/M18-0852. Epub 2018 Oct 9.

Supplemental Content

Support Center